109 related articles for article (PubMed ID: 8504497)
1. Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction.
Collen D; Van de Werf F
Circulation; 1993 Jun; 87(6):1850-3. PubMed ID: 8504497
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
[TBL] [Abstract][Full Text] [Related]
3. Staphylokinase: fibrinolytic properties and current experience in patients with occlusive arterial thrombosis.
Collen D; Lijnen HR; Vanderschueren S
Verh K Acad Geneeskd Belg; 1995; 57(3):183-96; discussion 196-8. PubMed ID: 7483814
[TBL] [Abstract][Full Text] [Related]
4. A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis.
Vanderschueren S; Collen D; van de Werf F
Thromb Haemost; 1996 Oct; 76(4):541-4. PubMed ID: 8902993
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase.
Vanderschueren S; Stockx L; Wilms G; Lacroix H; Verhaeghe R; Vermylen J; Collen D
Circulation; 1995 Oct; 92(8):2050-7. PubMed ID: 7554181
[TBL] [Abstract][Full Text] [Related]
6. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons.
Collen D; De Cock F; Stassen JM
Circulation; 1993 Mar; 87(3):996-1006. PubMed ID: 8443918
[TBL] [Abstract][Full Text] [Related]
7. Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction.
Vanderschueren S; Dens J; Kerdsinchai P; Desmet W; Vrolix M; De Man F; Van den Heuvel P; Hermans L; Collen D; Van de Werf F
Am Heart J; 1997 Aug; 134(2 Pt 1):213-9. PubMed ID: 9313600
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and induction of circulating antibodies against recombinant staphylokinase.
Declerck PJ; Vanderschueren S; Billiet J; Moreau H; Collen D
Thromb Haemost; 1994 Jan; 71(1):129-33. PubMed ID: 8165631
[TBL] [Abstract][Full Text] [Related]
9. On the immunogenicity of recombinant staphylokinase in patients and in animal models.
Vanderschueren SM; Stassen JM; Collen D
Thromb Haemost; 1994 Aug; 72(2):297-301. PubMed ID: 7831668
[TBL] [Abstract][Full Text] [Related]
10. Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.
Popović AD; Nesković AN; Babić R; Obradović V; Bozinović L; Marinković J; Lee JC; Tan M; Thomas JD
Circulation; 1994 Aug; 90(2):800-7. PubMed ID: 8044951
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and thrombolytic potential of staphylokinase.
Lijnen HR
Verh K Acad Geneeskd Belg; 1995; 57(4):303-14. PubMed ID: 8571666
[TBL] [Abstract][Full Text] [Related]
12. Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction.
Collen D; Sinnaeve P; Demarsin E; Moreau H; De Maeyer M; Jespers L; Laroche Y; Van de Werf F
Circulation; 2000 Oct; 102(15):1766-72. PubMed ID: 11023930
[TBL] [Abstract][Full Text] [Related]
13. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
GUSTO Angiographic Investigators
N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
[TBL] [Abstract][Full Text] [Related]
14. [Staphylokinase--a specific plasminogen activator].
Rozpończyk E; Szemraj J; Malinowski M; Rozpończyk J
Postepy Biochem; 2006; 52(1):80-6. PubMed ID: 16869305
[TBL] [Abstract][Full Text] [Related]
15. [Thrombolytic effects of recombinant staphylokinase on coronary thrombosis in miniature pigs].
Li G; Fang XL; Ren Z; Li KQ; Zhou SH; Hu DQ; Wu GQ; Wang TL; Li WP
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Jul; 36(4):369-374. PubMed ID: 33167101
[TBL] [Abstract][Full Text] [Related]
16. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
[TBL] [Abstract][Full Text] [Related]
17. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. TEAM-2 Investigators. Second Multicenter Thrombolytic Trials of Eminase in Acute Myocardial Infarction.
Gomez MA; Karagounis LA; Allen A; Anderson JL
Am J Cardiol; 1993 Aug; 72(5):373-8. PubMed ID: 8352177
[TBL] [Abstract][Full Text] [Related]
18. Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS).
Armstrong PW; Burton JR; Palisaitis D; Thompson CR; Van de Werf F; Rose B; Collen D; Teo KK
Am Heart J; 2000 May; 139(5):820-3. PubMed ID: 10783215
[TBL] [Abstract][Full Text] [Related]
19. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up.
Maes A; Van de Werf F; Nuyts J; Bormans G; Desmet W; Mortelmans L
Circulation; 1995 Oct; 92(8):2072-8. PubMed ID: 7554184
[TBL] [Abstract][Full Text] [Related]
20. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
